Search Results 751-760 of 17859 for Assay

  1. Brain Tumor Program - Clinical trials

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  2. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. Evaluate REC-4881 in Patients With FAP (TUPELO). Scottsdale/Phoenix, Ariz., Rochester, Minn. The ...

  3. Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer - Mayo Clinic

    mutation) (MAF) less than 2% by Guardant360 assay. - Detection of at least one of the following gene mutation(s) or amplification(s) by. Guardant360 assay.

  4. Blood Transfusion Clinical Trials - Mayo Clinic Research

    Participants enrolled in the prior Vanguard ... Laboratory Assay Optimization 2.0 Rochester, MN. The purpose of this study is to better understand the role ...

  5. Clinical trials - Oncology (Medical)

    ... assayed from blood of cases with CAP and controls without history of cancer. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic ...

  6. Liver Transplant Clinical Trials - Mayo Clinic Research

    The purpose of this study is to validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results ...

  7. A Study To Evaluate The Effects Of Two Doses Of MBX-8025 In Subjects With Primary Biliary Cirrhosis - Mayo Clinic

    ... assay (ELISA) or positive PBC-specific antinuclear antibodies; Documented liver biopsy result consistent with PBC. On a stable and recommended dose of ...

  8. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    ... assay within 9 months of symptom onset * Historically known positivity to an intracellular antigen with high cancer association or GAD-65 * Historically ...

  9. Thomas P. Burghardt, Ph.D. - Mayo Clinic Faculty Profiles

    Project involves rational protein design, muscle protein biochemistry, enzyme assay, microscope-based motility measurements and molecular dynamics simulation.

  10. Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) - Mayo Clinic

    * Participant has documented HIV infection by any licensed assay or documented history of detectable HIV-1 RNA. * Participant is ≥ 18 years old. * Cluster ...